Loading the session
Loading the session
Loading instrument
$65.67
+0.22%DelayedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 20:27 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
Closed at $65.53 on 4 Nov 2026: 0.7% below the 52-week high of $66.02 (4 Nov 2026) and 158.4% above the low of $25.36 (2 Jun 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
1 month: +22.1% (SPY −1.6%, XLV +13.5%). 3 months: +66.6% (SPY −0.4%, XLV +15.5%). 1 year: +100.1% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: ATRC, SPY and XLV · as of 4 Nov 2026
The 4 Nov 2026 gain of 8.5% was 3.9× its average daily move of 2.2% over the past year, and its largest one-day gain since 15 Jan 2026.
Daily closes, split-adjusted · as of 4 Nov 2026
4.9M shares were sold short at the 15 Oct 2026 settlement, 9.6% of the 50.9M shares outstanding; covering them would take 5.2 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
The 4 Nov 2026 close of $65.53 was 16.3% above its 50-day average ($56.36) and 70.6% above its 200-day average ($38.42). It has closed above the 200-day for 73 sessions, since 24 Jul 2026. The 50-day average crossed above the 200-day on 13 Aug 2026, 58 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
February 11, 2026
−13.11%April 30, 2025
−13.68%October 30, 2024
+18.35%